Literature DB >> 27769807

Cytokine profiles in Opisthorchis viverrini stimulated peripheral blood mononuclear cells from cholangiocarcinoma patients.

Arpa Surapaitoon1, Sutas Suttiprapa2, Narong Khuntikeo3, Chawalit Pairojkul4, Banchob Sripa5.   

Abstract

The carcinogenic liver fluke Opisthorchis viverrini causes chronic inflammation in the bile duct and resulting in unremitting tissue damage that lead to hepatobiliary diseases, including cholangiocarcinoma (CCA). Despite inflammatory cytokine expression having been studied in the animal model, so far no studies have been carried out on cytokines in human CCA cases. Here we report the profile of cytokine production in peripheral blood mononuclear cells (PBMCs) collected from O. viverrini-associated human CCA and uninfected normal controls after stimulation with O. viverrini-excretory secretory (ES) product. Eleven cytokine profiles including IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, TNF-α and LT-α measured by flow cytometry revealed both pro-inflammatory and anti-inflammatory cytokines were increased in the O. viverrini-associated CCA compared to uninfected normal controls. Specifically, net production levels of IFN-γ, IL-10, and LT-α were 40 to >320 times higher in CCA than those of controls. These results suggest dysregulation of the immune response in the liver fluke associated CCA. Copyright Â
© 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cholangiocarcinoma; Cytokines; Liver fluke; Opisthorchis viverrini; PBMCs

Mesh:

Substances:

Year:  2016        PMID: 27769807      PMCID: PMC5125871          DOI: 10.1016/j.parint.2016.10.009

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  22 in total

Review 1.  Cytokine gene polymorphism in human disease: on-line databases.

Authors:  J Bidwell; L Keen; G Gallagher; R Kimberly; T Huizinga; M F McDermott; J Oksenberg; J McNicholl; F Pociot; C Hardt; S D'Alfonso
Journal:  Genes Immun       Date:  1999-09       Impact factor: 2.676

2.  Specific assays for cytokine production by T cells.

Authors:  T R Mosmann; T A Fong
Journal:  J Immunol Methods       Date:  1989-01-17       Impact factor: 2.303

Review 3.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 4.  Infection with the carcinogenic human liver fluke, Opisthorchis viverrini.

Authors:  Michael J Smout; Banchob Sripa; Thewarach Laha; Jason Mulvenna; Robin B Gasser; Neil D Young; Jeffrey M Bethony; Paul J Brindley; Alex Loukas
Journal:  Mol Biosyst       Date:  2011-02-11

Review 5.  Cytokinome profile evaluation in patients with hepatitis C virus infection.

Authors:  Francesca Capone; Eliana Guerriero; Giovanni Colonna; Patrizia Maio; Alessandra Mangia; Giuseppe Castello; Susan Costantini
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

6.  Opisthorchis viverrini excretory/secretory products induce toll-like receptor 4 upregulation and production of interleukin 6 and 8 in cholangiocyte.

Authors:  Kantima Ninlawan; Steve P O'Hara; Patrick L Splinter; Puangrat Yongvanit; Sasithorn Kaewkes; Arpa Surapaitoon; Nicholas F LaRusso; Banchob Sripa
Journal:  Parasitol Int       Date:  2010-09-29       Impact factor: 2.230

7.  Maternal acceptance, attitude and knowledge on human papilloma virus vaccination for their daughters.

Authors:  Karicha Mairaing; Komsun Suwannarurk; Yudthadej Thaweekul; Yenruedee Poomtavorn
Journal:  J Med Assoc Thai       Date:  2012-01

Review 8.  Cholangiocarcinoma: lessons from Thailand.

Authors:  Banchob Sripa; Chawalit Pairojkul
Journal:  Curr Opin Gastroenterol       Date:  2008-05       Impact factor: 3.287

9.  Human pathology of Opisthorchis viverrini infection: a comparison of adults and children.

Authors:  M Riganti; S Pungpak; B Punpoowong; D Bunnag; T Harinasuta
Journal:  Southeast Asian J Trop Med Public Health       Date:  1989-03       Impact factor: 0.267

10.  Elevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini.

Authors:  Banchob Sripa; Bandit Thinkhamrop; Eimorn Mairiang; Thewarach Laha; Sasithorn Kaewkes; Paiboon Sithithaworn; Maria Victoria Periago; Vajarabhongsa Bhudhisawasdi; Ponlapat Yonglitthipagon; Jason Mulvenna; Paul J Brindley; Alex Loukas; Jeffrey M Bethony
Journal:  PLoS Negl Trop Dis       Date:  2012-05-22
View more
  4 in total

1.  Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke Opisthorchis viverrini-Associated Advanced Periductal Fibrosis and Cholangiocarcinoma.

Authors:  Arpa Surapaitoon; Sutas Suttiprapa; Eimorn Mairiang; Narong Khuntikeo; Chawalit Pairojkul; Jeffrey Bethony; Paul J Brindley; Banchob Sripa
Journal:  Korean J Parasitol       Date:  2017-06-30       Impact factor: 1.341

2.  Opisthorchiasis with proinflammatory cytokines (IL-1β and TNF-α) polymorphisms influence risk of intrahepatic cholangiocarcinoma in Thailand: a nested case-control study.

Authors:  Supannee Promthet; Nopparat Songserm; Somkiattiyos Woradet; Chamsai Pientong; Tipaya Ekalaksananan; Surapon Wiangnon; Akhtar Ali
Journal:  BMC Cancer       Date:  2018-08-23       Impact factor: 4.430

3.  Opisthorchis felineus infection provokes time-dependent accumulation of oxidative hepatobiliary lesions in the injured hamster liver.

Authors:  Mariya Y Pakharukova; Oxana G Zaparina; Yaroslav K Kapushchak; Nina V Baginskaya; Viatcheslav A Mordvinov
Journal:  PLoS One       Date:  2019-05-14       Impact factor: 3.240

4.  A randomized placebo-controlled phase I clinical trial to evaluate the immunomodulatory activities of Atractylodes lancea (Thunb) DC. in healthy Thai subjects.

Authors:  Inthuon Kulma; Luxsana Panrit; Tullayakorn Plengsuriyakarn; Wanna Chaijaroenkul; Siriprapa Warathumpitak; Kesara Na-Bangchang
Journal:  BMC Complement Med Ther       Date:  2021-02-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.